Not finding it? Sign in to also search OpenAlex live.
-
Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study2023 Scandinavian Journal of Rheumatology article Medicine Spondyloarthritis Studies and Treatments Open access
Celia A J Michielsens, Thomas E. Bolhuis, Floris A van Gaalen, LM Verhoef, Nathan den Broeder, Alfons A den Broeder
14citations -
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis2021 The Journal of Rheumatology article Medicine Spondyloarthritis Studies and Treatments Open access
Peter Charles Taylor, Désirée M F M van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng, Annelies E. R. C. H. Boonen
14citations -
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A. Deodhar, Robert Davies Inman, Hideto Kameda, +6 more
129citations -
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study2023 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Désirée M F M van der Heijde, Joachim Sieper, Robert Davies Inman, Hideto Kameda, Yihan Li, +5 more
26citations -
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One‐Year Results of a Double‐Blind, Placebo‐Controlled Study and Open‐Label Extension
Atul A. Deodhar, Désirée M F M van der Heijde, Joachim Sieper, Filip E Van den Bosch, Walter P. Maksymowych, Tae‐Hwan Kim, +6 more
66citations -
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study
Xenofon Baraliakos, Atul A. Deodhar, Maxime Dougados, Lianne S. Gensler, Anna Moltó, Sofía Ramiro, +9 more
31citations -
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study2024 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Désirée M F M van der Heijde, J. Sieper, Robert Davies Inman, Hideto Kameda, Walter P. Maksymowych, +6 more
21citations -
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Atul A. Deodhar, Paula Śliwińska-Stańczyk, Huji Xu, Xenofon Baraliakos, Lianne S. Gensler, Dona L. Fleishaker, +8 more
260citations -
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Désirée M F M van der Heijde, Lianne S. Gensler, Atul A. Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, +6 more
134citations -
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)2020 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Casper Webers, C. Stolwijk, Olga J.G. Schiepers, Thea H.M. Schoonbrood, Astrid M van Tubergen, Robert Landewé, +2 more
18citations -
Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension
Atul A. Deodhar, Victoria Navarro‐Compán, Denis Poddubnyy, Lianne S. Gensler, Sofía Ramiro, Tetsuya Tomita, +7 more
11citations -
Can radiologic parameters used to detect cervical spinal instability be used in patients with ankylosing spondylitis?2023 European journal of medical research article Medicine Spinal Fractures and Fixation Techniques Open access
Henrik Teuber, Sascha Halvachizadeh, Melvin Muthirakalayil, Luxu Yin, Harry Eisenkrein, Frank Hildebrand, +6 more
2citations -
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature2023 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Anna Moltó, Sofía Ramiro, Jürgen Braun, Maxime Dougados, Floris A van Gaalen, +17 more
118citations -
OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
D. van der Heijde, Xenofon Baraliakos, Maxime Dougados, M. Brown, Denis Poddubnyy, Filip E Van den Bosch, +9 more
5citations -
POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
D. van der Heijde, Xenofon Baraliakos, Joachim Sieper, A. Deodhar, Robert Davies Inman, H. Kameda, +6 more
3citations -
POS0226 BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Atul A. Deodhar, Lianne S. Gensler, Denis Poddubnyy, Alan Kivitz, Maxime Dougados, +5 more
3citations -
POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
Atul A. Deodhar, V. Navarro-Compán, Denis Poddubnyy, Lianne S. Gensler, Sofía Ramiro, T. Tomita, +6 more
2citations -
OP0141 EFFECTS OF FILGOTINIB ON SPINAL LESIONS IN ANKYLOSING SPONDYLITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE TORTUGA TRIAL2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Mikkel Østergaard, R. B. M. Landewé, William Barchuk, K. Liu, Chantal T. Tasset, +4 more
2citations